These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7530071)

  • 1. Current status and future prospects for the treatment of lung disease in cystic fibrosis by gene therapy.
    Porteous DJ
    Pulm Pharmacol; 1994 Jun; 7(3):153-7. PubMed ID: 7530071
    [No Abstract]   [Full Text] [Related]  

  • 2. A mixed message for cystic fibrosis gene therapy.
    Alton E; Geddes D
    Nat Genet; 1994 Sep; 8(1):8-9. PubMed ID: 7527272
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of CF gene therapy.
    Boucher RC
    Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy for cystic fibrosis: current issues.
    Southern KW
    Br J Hosp Med; 1996 Apr 17-30; 55(8):495-9. PubMed ID: 8732222
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis. Vehicles for gene therapy.
    Wilson JM
    Nature; 1993 Oct; 365(6448):691-2. PubMed ID: 7692307
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy: development of adenovirus vectors].
    Siegfried W
    Pneumologie; 1996 Dec; 50 Suppl 3():860-4. PubMed ID: 9157443
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene therapy in cystic fibrosis: from lab benches to lungs.
    Arthur G
    Lancet Respir Med; 2015 Jul; 3(7):521-2. PubMed ID: 26070912
    [No Abstract]   [Full Text] [Related]  

  • 10. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.
    Crystal RG; McElvaney NG; Rosenfeld MA; Chu CS; Mastrangeli A; Hay JG; Brody SL; Jaffe HA; Eissa NT; Danel C
    Nat Genet; 1994 Sep; 8(1):42-51. PubMed ID: 7527271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for cystic fibrosis: which postman, which box?
    Middleton PG; Alton EW
    Thorax; 1998 Mar; 53(3):197-9. PubMed ID: 9659356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
    Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
    Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of cystic fibrosis: a paradigm for uncovering new drug targets.
    Boucher RC
    Curr Opin Biotechnol; 1994 Dec; 5(6):639-42. PubMed ID: 7531034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis gene therapy.
    Colledge WH
    Curr Opin Genet Dev; 1994 Jun; 4(3):466-71. PubMed ID: 7522673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for cystic fibrosis.
    Flotte TR
    Curr Opin Mol Ther; 1999 Aug; 1(4):510-6. PubMed ID: 11713767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. A phase I study.
    Hum Gene Ther; 1994 Aug; 5(8):1019-57. PubMed ID: 7948139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.